Drug Trial Radar · NCT00992459
Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
Last checked: Nov 20, 2026Latest source record: Jul 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Oct 2009
Primary completion
Sep 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Oct 9, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a randomized, active-controlled, double-blind, cross-over study designed to enroll subjects with UCDs who are being treated with NaPBA.
Conditions
- Urea Cycle Disorders
Interventions
HPN-100Drug
HPN-100 is a triglyceride that has a similar mechanism of action as NaPBA. It is a liquid with minimal taste and odor. Three teaspoons of HPN-100 (\~17.4mL) delivers equivalent amount of PBA in 40 tablets of NaPBA.
Buphenyl (NaPBA)Drug
Buphenyl (NaPBA) will be the comparator drug to HPN-100 in this study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Primary Endpoint Was the 24-hour Area Under the Curve for Blood Ammonia (NH324-hour AUC) on Days 14 and 28.Time frame: pre-dose, 2, 4, 8, 12, 16, 20 and 24 hours after first dose on days 14 and 28
Locations
22 sites in 2 countries. Site status is shown where the registry gives one.
Long Beach Memorial
Long Beach, California
UCLA
Los Angeles, California
Stanford University
Stanford, California
Denver Children's Hospital
Aurora, Colorado
Yale School of Medicine
New Haven, Connecticut
Children's National Medical Center
Washington D.C., District of Columbia
University of Florida
Gainesville, Florida
University of Iowa
Iowa City, Iowa
Maine Medical Center
Portland, Maine
SNBL-Clinical Pharmacology Center
Baltimore, Maryland
Tufts-New England Medical Center
Boston, Massachusetts
University of Minnesota Medical Center
Minneapolis, Minnesota
Mount Sinai School of Medicine
New York, New York
Westchester Medical Center
Valhalla, New York
University Hospitals Case Medical Center
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Oregon Health & Science University
Portland, Oregon
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania
Baylor College of Medicine
Houston, Texas
University of Utah
Salt Lake City, Utah
Medical College of Wisconsin
Milwaukee, Wisconsin
The Hospital for Sick Children
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.